Search Results - joseph+pisegna

2 Results

Sort By:

SYNERGISM BETWEEN PROTON PUMP INHIBITORS AND A GI PEPTIDE IN REDUCING ACID SECRETION

Case 2000-093UCLA researchers in the Department of Medicine have discovered a novel method to improve the efficacy of proton pump inhibition. BACKGROUND:A vast number of pathological conditions are characterized by over-secretion of gastric acid, such as Zollinger/Ellison syndrome (ZES), gastroesophageal reflux disease (GERD), peptic ulcer disease,...

Published: 7/19/2023 | Inventor(s): Joseph Pisegna

Keywords(s): Gastroenterology & Digestive Disease, Renal, Therapeutics & Vaccines

Category(s): Therapeutics > Gastroenterology, Therapeutics > Renal

2018-199 Identification of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, and Hepatic Fibrosis

Identification Of OLMAINC as a Biomarker for NAFLD, NASH, Metabolic Syndrome, Hepatic FibrosisSUMMARYUCLA researchers in the Departments of Medicine and Human Genetics have identified a sequence of long, non-coding RNA that plays a role in the regulation of intracellular lipogenesis and holds potential for diagnosing and treating metabolic diseases,...

Published: 7/19/2023 | Inventor(s): Jihane Benhammou, Paivi Pajukanta, Joseph Pisegna

Keywords(s): Diagnostic Markers & Platforms, Metabolic Diseases, Therapeutics & Vaccines

Category(s): Diagnostic Markers, Therapeutics, Therapeutics > Metabolism And Endocrinology